Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIFEDIPINE for Primary hyperaldosteronism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where NIFEDIPINE was used for Primary hyperaldosteronism.

Most Reported Side Effects for NIFEDIPINE

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 927 11.2% 77 176
Drug ineffective 883 10.7% 23 245
Premature baby 791 9.6% 25 144
Maternal exposure during pregnancy 704 8.5% 6 252
Premature delivery 555 6.7% 2 150
Exposure during pregnancy 524 6.3% 4 149
Hypotension 505 6.1% 81 304
Off label use 474 5.7% 19 102
Drug hypersensitivity 459 5.6% 4 25
Completed suicide 431 5.2% 428 129
Toxicity to various agents 413 5.0% 234 235
Low birth weight baby 346 4.2% 12 98
Hypertension 329 4.0% 10 161
Dyspnoea 320 3.9% 16 126
Headache 317 3.8% 8 92

Other Indications for NIFEDIPINE

Product used for unknown indication (2,448) Hypertension (2,331) Foetal exposure during pregnancy (220) Tocolysis (209) Pre-eclampsia (136) Blood pressure abnormal (125) Blood pressure increased (107) Raynaud's phenomenon (102) Blood pressure measurement (100) Blood pressure management (80)

Other Drugs Used for Primary hyperaldosteronism

SPIRONOLACTONE (50) EPLERENONE (36) METOPROLOL (9) POTASSIUM (9) AMLODIPINE (6)

Related Pages

NIFEDIPINE Full Profile All Primary hyperaldosteronism Drugs NIFEDIPINE Demographics NIFEDIPINE Timeline